Diphenhydramine Safety in Pregnancy
Diphenhydramine can be used during pregnancy when necessary, but chlorpheniramine, cetirizine, or loratadine are preferred alternatives due to better documented safety profiles, and first-trimester exposure to diphenhydramine should be avoided when possible due to concerns about cleft palate. 1
Safety Profile and Risk Assessment
First Trimester Concerns
- The American College of Allergy, Asthma, and Immunology recommends using diphenhydramine with caution during pregnancy, particularly in the first trimester, due to a possible association with cleft palate, though recent studies have not conclusively confirmed this risk. 1
- The first trimester represents the most critical period for concern about congenital malformations because organogenesis occurs during this time. 1, 2
- An older case-control study suggested an association between first-trimester diphenhydramine exposure and cleft palate, but this finding has not been sufficiently refuted or confirmed by subsequent research. 1, 3
Overall Safety Evidence
- Recent studies have not detected significant increased risk for congenital malformations with diphenhydramine use during pregnancy, but caution remains advised. 1
- Both first-generation and second-generation antihistamines generally have good safety records during pregnancy. 1
- The FDA label advises pregnant women to ask a healthcare professional before use. 4
Preferred Alternative Antihistamines
When antihistamine treatment is necessary during pregnancy, the following hierarchy should guide selection:
Chlorpheniramine (first choice): Recommended as the first-line antihistamine during pregnancy due to its observed safety and longevity of use. 1, 2
Cetirizine and Loratadine: FDA Pregnancy Category B drugs with more accumulated safety data than diphenhydramine; these second-generation antihistamines have confirmed safety through large birth registries, case-control studies, and cohort studies. 1, 2
Diphenhydramine (use with caution): May be used when preferred alternatives are unavailable or ineffective, but avoid first-trimester exposure when possible. 1
Clinical Indications and Dosing
Approved Uses
- Diphenhydramine is indicated for allergic reactions including anaphylaxis, urticaria, and allergic rhinitis. 5
- In anaphylaxis management, diphenhydramine 1-2 mg/kg or 25-50 mg/dose can be administered parenterally. 6
- The combination of diphenhydramine and ranitidine is superior to diphenhydramine alone in managing anaphylaxis. 6
Dosing Considerations
- Standard adult dosing ranges from 25-50 mg per dose. 6
- Pediatric dosing is 1-2 mg/kg. 6
- Despite over-the-counter availability, adverse physiologic effects and toxicity may occur, especially when administered rapidly intravenously or in large doses. 5
Important Clinical Pitfalls
Combination Products
- Avoid combining diphenhydramine with oral decongestants during the first trimester due to potential risks of congenital malformations including gastroschisis and small intestinal atresia. 2, 3
- Combining decongestants with acetaminophen or salicylates may increase the risk of malformations. 2, 3
Common Misconceptions
- Do not assume all antihistamines have equivalent safety profiles during pregnancy—they do not, and specific agents have better documented safety. 1, 2
- Diphenhydramine is widely used during pregnancy (used by at least 15% of pregnant women in observational studies), but this frequency of use does not equate to superior safety compared to alternatives. 7
Alternative Non-Antihistamine Options
When treating allergic symptoms in pregnancy, consider these safer alternatives:
- Intranasal corticosteroids (e.g., budesonide): May be used with a favorable safety profile. 2
- Sodium cromolyn nasal spray: Considered safe during pregnancy (FDA Category B), though requires frequent dosing. 2
- Montelukast: FDA Pregnancy Category B with reassuring animal reproductive studies. 2
Monitoring Recommendations
- If diphenhydramine must be used during pregnancy, monitor fetal development through routine prenatal care. 1
- Consider switching to safer alternative antihistamines (chlorpheniramine, cetirizine, or loratadine) if treatment is needed throughout pregnancy. 1
- The FDA label warns about marked drowsiness, excitability (especially in children), and advises keeping out of reach of children due to overdose risk. 4